Clinical Trials Logo

Vitreomacular Traction clinical trials

View clinical trials related to Vitreomacular Traction.

Filter by:

NCT ID: NCT06038968 Completed - Clinical trials for Diabetic Retinopathy

Methotrexate Infusion and Intrasilicone Injection During Diabetic Vitrectomy

Start date: September 1, 2022
Phase: Early Phase 1
Study type: Interventional

The goal of this interventional clinical trial is to assess anatomical and functional outcomes of methotrexate use in irrigating fluid during parsplana vitrectomy combined with intrasilicone injection at end of surgery in patients with advanced proliferative diabetic retinopathy. The main questions it aims to answer are: 1. Does methotrexate use in irrigating fluid during parsplana vitrectomy combined with intrasilicone injection at end of surgery decrease the post operative vitreoretinal proliferation after vitrectomy in patients with advanced proliferative diabetic retinopathy? 2. Does methotrexate use in irrigating fluid during parsplana vitrectomy combined with intrasilicone injection at end of surgery improve post operative functional outcome after vitrectomy in patients with advanced proliferative diabetic retinopathy? Researchers will compare the anatomical and functional outcomes after vitrectomy in patients with advanced proliferative diabetic retinopathy without using methotrexate.

NCT ID: NCT05860985 Recruiting - Retinal Detachment Clinical Trials

Zeiss RESIGHT Disposable Lenses Evaluation Study

RESIGHT
Start date: April 11, 2023
Phase: N/A
Study type: Interventional

To evaluate the intra-operative efficacy of a new intra-operative viewing device.

NCT ID: NCT05588037 Recruiting - Cataract Clinical Trials

Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Based on the progress of cataract surgery, intraocular lens development, vitreoretinal surgery and anesthesia technology in recent years, the purpose of this study is to develop a new type of more accurate and minimally invasive combined surgery for cataract and fundus diseases, and to evaluate the advantages and value of the surgery as well as related complications, so as to minimize the surgical trauma and obtain faster visual function recovery and better patient comfort. To provide new solutions for the growing demand of eye health care.

NCT ID: NCT05517473 Completed - Macular Holes Clinical Trials

Efficacy and Safety Evaluation of MONOBLUE DUAL View and MONOBLUE ILM View Vital Stains

NewBlueDyes
Start date: July 5, 2022
Phase:
Study type: Observational

In this study, the investigators aim to collect data regarding the efficiency and safety of two dyes used intraoperatively in vitrectomy to stain intraocular tissues. These products have the necessary approvals to use during such operation,These are NOT experimental products.

NCT ID: NCT05287269 Completed - Clinical trials for Age Related Macular Degeneration

Ocular Coherence Tomography During Cataract Assessment

Start date: November 2, 2020
Phase:
Study type: Observational [Patient Registry]

Many patients will have underlying maculopathy present when undergoing cataract surgery, which are not visible on fundoscopy alone. Knowledge of this underlying pathology will allow an improved consenting process and discussion with the patient regarding the risks, visual prognosis and recovery following cataract surgery. Incidental findings in the fellow eye would also allow for improved diagnosis and management of these patients without adding significant additional time to specialist high volume cataract assessment clinics.

NCT ID: NCT04300881 Terminated - Clinical trials for Vitreomacular Traction

Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid Antagonists)

TOTEM
Start date: October 4, 2019
Phase: Phase 2
Study type: Interventional

Evaluate the efficacy of eplerenone as an adjunctive treatment to intravitreal ocriplasmin for subretinal fluid in comparison to a control group of only receiving intravitreal ocriplasmin in patients with symptomatic vitreomacular adhesion.

NCT ID: NCT03647267 Completed - Clinical trials for Vitreomacular Traction

Effects of Pneumatic Vitreolysis on Vitreomacular Traction

AG
Start date: October 16, 2018
Phase: Phase 3
Study type: Interventional

Eyes with idiopathic symptomatic vitreomacular traction (VMT) without a macular hole will be randomly assigned to 0.3-mL intraocular gas (C3F8) injection or sham injection to determine if pneumatic vitreolysis (PVL) is effective in releasing VMT.

NCT ID: NCT02322229 Completed - Clinical trials for Vitreomacular Traction

Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion

Start date: May 26, 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to observe the anatomical and functional outcomes of ocriplasmin (JETREA™®) over a 6-month period.

NCT ID: NCT02290795 Recruiting - Glaucoma Clinical Trials

Vitreopapillary Interface and Optic Disc Morphology

Start date: November 2014
Phase: N/A
Study type: Observational

The vitreous fills the posterior chamber of the eye and is firmly attached, at the posterior pole, to the macula and the optic nerve head (ONH). With formation of a stepwise posterior vitreous detachment (PVD) exerted tractional forces could influence retinal functioning. Especially in patients with glaucoma the influence of vitreous traction to the ONH could mask progression, interfere with current imaging techniques and even be a cause of ONH hemorrhages. Therefore the aim of this study is to investigate whether vitreopapillary traction has a significant effect on diagnosis and follow up of glaucoma patients.

NCT ID: NCT02035748 Completed - Clinical trials for Vitreomacular Traction

Assessment of Patients Treated With JETREA® for Vitreomacular Traction

Start date: April 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to observe the anatomical and functional outcomes of ocriplasmin (JETREA®) over a 6-month follow-up period.